- Home
- TTD vs ELAN Comparison
TTD vs ELAN Comparison
Compare TTD & ELAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TTD | ELAN |
|---|---|---|
| Founded | 2009 | 1954 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Programming Data Processing | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.0B | 12.7B |
| IPO Year | 2016 | 2018 |
Fundamental Metrics
Financial Performance| Metric | TTD | ELAN |
|---|---|---|
| Price | $20.07 | $22.99 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 34 | 9 |
| Target Price | ★ $46.63 | $27.63 |
| AVG Volume (30 Days) | ★ 18.0M | 5.3M |
| Earning Date | 05-07-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 15.38 | N/A |
| EPS | ★ 0.90 | N/A |
| Revenue | $2,896,284,000.00 | ★ $4,715,000,000.00 |
| Revenue This Year | $14.01 | $8.21 |
| Revenue Next Year | $12.63 | $5.29 |
| P/E Ratio | $22.92 | ★ N/A |
| Revenue Growth | ★ 18.47 | 6.22 |
| 52 Week Low | $19.74 | $8.02 |
| 52 Week High | $91.45 | $27.72 |
Technical Indicators
Market Signals| Indicator | TTD | ELAN |
|---|---|---|
| Relative Strength Index (RSI) | 31.84 | 43.74 |
| Support Level | N/A | $22.17 |
| Resistance Level | $28.59 | $25.65 |
| Average True Range (ATR) | 1.25 | 1.02 |
| MACD | -0.09 | -0.07 |
| Stochastic Oscillator | 7.13 | 25.84 |
Price Performance
Historical ComparisonAbout TTD The Trade Desk Inc.
The Trade Desk provides a self-service platform that helps advertisers and ad agencies programmatically find and purchase digital ad inventory (display, video, audio, and social) on devices like computers, smartphones, and connected TVs. It uses data in an iterative manner to optimize the performance of ad impressions purchased. The firm's platform is referred to as a demand-side platform in the digital ad industry, and it generates revenue from fees based on a percentage of what its clients spend on advertising.
About ELAN Elanco Animal Health Incorporated
Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, goats, and swine production.